Kim De Veirman

9PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 29, 2025
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy.

Arne Van der Vreken, Fabien Thery, Chenggong Tu

|Jun 19, 2024
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.

Heleen Hanssens, Fien Meeus, Emma L Gesquiere

|Dec 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.

Rong Fan, Hatice Satilmis, Niels Vandewalle

|Jan 17, 2023
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.

Rong Fan, Hatice Satilmis, Niels Vandewalle

|Oct 17, 2022
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.

Hatice Satilmis, Emma Verheye, Philip Vlummens

|Jan 21, 2022
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.

Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker

Pageof 2

Frequent Collaborators

4 joint publications

Eline Menu

3 joint publications

Ken Maes

3 joint publications

Elke De Bruyne

3 joint publications

Heleen Hanssens